Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients

about

Mineral and bone disorder after kidney transplantation Vitamin D status and viral response to therapy in hepatitis C infected children.

P2860

Q26771398-D06B14F8-F423-402A-A527-B4E57BA237AB Q35012136-D868C6DF-893F-4C69-AC21-86B0FDEA5B4C

P2860

Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients

Item

http://www.wikidata.org/entity/Q28487941

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Impact of hepatitis C virus in ...... in renal transplant recipients

@ast

Impact of hepatitis C virus in ...... in renal transplant recipients

@en

Impact of hepatitis C virus in ...... in renal transplant recipients

@nl

type

Item

label

Impact of hepatitis C virus in ...... in renal transplant recipients

@ast

Impact of hepatitis C virus in ...... in renal transplant recipients

@en

Impact of hepatitis C virus in ...... in renal transplant recipients

@nl

prefLabel

Impact of hepatitis C virus in ...... in renal transplant recipients

@ast

Impact of hepatitis C virus in ...... in renal transplant recipients

@en

Impact of hepatitis C virus in ...... in renal transplant recipients

@nl

P1476

Impact of hepatitis C virus in ...... in renal transplant recipients

@en

P2093

Jeng-Yi Huang

http://www.w3.org/2001/XMLSchema#string

Mei-Ching Yu

http://www.w3.org/2001/XMLSchema#string

Ping-Chin Lai

http://www.w3.org/2001/XMLSchema#string

Wen-Hung Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

Classical and emerging roles of vitamin D in hepatitis C virus infection

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

TRANCE is a TNF family member that regulates dendritic cell and osteoclast function

Use of alendronate sodium (Fosamax) to ameliorate osteoporosis in renal transplant patients: a case-control study

P304

e63263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0063263

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236910224

http://www.w3.org/2001/XMLSchema#string

P698

23675468

http://www.w3.org/2001/XMLSchema#string

P932

3652826

http://www.w3.org/2001/XMLSchema#string

Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients

about

P2860

P2860

Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932